Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of infection

Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of infection

Background and Aim: Inhibition of gastric acid secretion is important for eradicating Helicobacter pylori . Vonoprazan (VPZ) is a strong, long-lasting inhibitor of gastric acid secretion. Studies that examined the effectiveness of VPZ-based triple therapy in second-line treatment have been performed...

Full description

Bibliographic Details
Main Authors: Mariko Hojo, Daisuke Asaoka, Tsutomu Takeda, Yuji Shimada, Kenshi Matsumoto, Kohei Matsumoto, Noboru Yatagai, Yoichi Akazawa, Kumiko Ueda, Hiroya Ueyama, Akihito Nagahara
Format: Article
Language:English
Published: SAGE Publishing 2020-11-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756284820966247

Internet

https://doi.org/10.1177/1756284820966247

Similar Items